Solid oral dosage formulation Patents expiring by the year 2013


List of Solid oral dosage formulation Patents expiring by the year 2013

Click on the application number to visit the official ORANGE BOOK web site for
further details(Recommended)

Please click on the links to visit the official website USPTO for complete patent details.

http://patft.uspto.gov/netahtml/PTO/srchnum.htm

http://www.uspto.gov/

A
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020977 1 ABACAVIR SULFATE 5034394 18-Dec-11 Y Y

N020977 1 ABACAVIR SULFATE 5034394*PED 18-Jun-12



N020560 1 ALENDRONATE SODIUM 5358941 2-Dec-12



N020560 1 ALENDRONATE SODIUM 5358941*PED 2-Jun-13



N020560 1 ALENDRONATE SODIUM 5681590 2-Dec-12



N020560 1 ALENDRONATE SODIUM 5681590*PED 2-Jun-13



N020560 1 ALENDRONATE SODIUM 6090410 2-Dec-12



N020560 1 ALENDRONATE SODIUM 6090410*PED 2-Jun-13



N020560 1 ALENDRONATE SODIUM 6194004 2-Dec-12



N020560 1 ALENDRONATE SODIUM 6194004*PED 2-Jun-13



N021762 1 ALENDRONATE SODIUM; CHOLECALCIFEROL 5358941 2-Dec-12
Y

N021762 1 ALENDRONATE SODIUM; CHOLECALCIFEROL 5358941*PED 2-Jun-13



N021287 1 ALFUZOSIN HYDROCHLORIDE 4661491 18-Jan-11

U-706
N021287 1 ALFUZOSIN HYDROCHLORIDE 4661491*PED 18-Jul-11



N022217 1 ALISKIREN HEMIFUMARATE; VALSARTAN 5399578 21-Mar-12 Y Y U-3
N021107 1 ALOSETRON HYDROCHLORIDE 5360800 13-Jan-13 Y Y U-405
N021775 1 ALVIMOPAN 5434171 8-Dec-13 Y Y U-878
N021540 1 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM RE40667 28-Dec-10 Y Y U-162
N021540 1 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM RE40667*PED 28-Jun-11



N021540 1 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 5273995 28-Dec-10 Y Y U-162
N021540 1 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 5273995*PED 28-Jun-11



N021540 1 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 6126971*PED 19-Jul-13



N021540 2 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 6126971 19-Jan-13
Y

N022314 1 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN 5399578 21-Mar-12 Y Y U-3
N022314 1 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN 5399578*PED 21-Sep-12



N021549 1 APREPITANT 5145684 25-Jan-11
Y

N021549 1 APREPITANT 5538982 23-Jul-13

U-745
N021549 1 APREPITANT 6235735 29-Jun-12

U-746
N021549 1 APREPITANT 7214692 18-Sep-12

U-853
N021875 4 ARMODAFINIL 4927855*PED 22-Oct-10



N020702 1 ATORVASTATIN CALCIUM 5273995 28-Dec-10 Y Y U-162
N020702 1 ATORVASTATIN CALCIUM 5273995*PED 28-Jun-11

U-162
N020702 1 ATORVASTATIN CALCIUM RE40667*PED 28-Jun-11



N020702 1 ATORVASTATIN CALCIUM 6126971 19-Jan-13
Y

N020702 1 ATORVASTATIN CALCIUM 6126971*PED 19-Jul-13



N021078 1 ATOVAQUONE; PROGUANIL HYDROCHLORIDE 6166046 25-Nov-13

U-406
N021078 1 ATOVAQUONE; PROGUANIL HYDROCHLORIDE 5998449 25-Nov-13

U-990
N021078 1 ATOVAQUONE; PROGUANIL HYDROCHLORIDE 6291488 25-Nov-13

U-406
N200796 1 AZILSARTAN MEDOXOMIL 5736555 25-Jun-12 Y Y U-3
N200796 2 AZILSARTAN MEDOXOMIL 5736555 25-Jun-12 Y Y U-3
N200796 1 AZILSARTAN MEDOXOMIL 5583141 10-Dec-13 Y Y U-3
B
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N021055 1 BEXAROTENE 6043279 22-Apr-12

U-509
N021055 1 BEXAROTENE 6320074 22-Apr-12 Y
U-509
N021055 1 BEXAROTENE 7655699 22-Apr-12 Y Y U-509
N020866 1 BROMOCRIPTINE MESYLATE 5468755 21-Nov-12

U-976
N020866 1 BROMOCRIPTINE MESYLATE 5866584 21-Nov-12

U-976
N020866 1 BROMOCRIPTINE MESYLATE 5756513 21-Nov-12

U-976
N021324 1 BUDESONIDE 6423340 15-Nov-10



N021324 1 BUDESONIDE 6423340*PED 15-May-11



N020711 3 BUPROPION HYDROCHLORIDE 5427798 12-Aug-13



N020711 3 BUPROPION HYDROCHLORIDE 5358970 12-Aug-13



N020711 3 BUPROPION HYDROCHLORIDE 5763493 12-Aug-13



N020358 4 BUPROPION HYDROCHLORIDE 5731000 12-Aug-13



C
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020838 1 CANDESARTAN CILEXETIL 5534534 9-Jul-13
Y

N020838 1 CANDESARTAN CILEXETIL 5196444 4-Jun-12 Y Y U-3
N020838 1 CANDESARTAN CILEXETIL 5196444*PED 4-Dec-12



N020838 1 CANDESARTAN CILEXETIL 5705517 18-Apr-11 Y Y U-660
N020838 1 CANDESARTAN CILEXETIL 5705517*PED 18-Oct-11



N020838 1 CANDESARTAN CILEXETIL 7538133 18-Apr-11 Y


N020838 1 CANDESARTAN CILEXETIL 7538133*PED 18-Oct-11



N020896 1 CAPECITABINE 5472949 14-Dec-13

U-271
N020896 1 CAPECITABINE 4966891 13-Jan-11

U-272
N018343 1 CAPTOPRIL 5238924 24-Aug-10

U-92
N020234 1 CARBAMAZEPINE 5284662 8-Feb-11



N020712 1 CARBAMAZEPINE 5326570 5-Jul-11

U-215
N021485 1 CARBIDOPA; ENTACAPONE; LEVODOPA 5135950 31-Oct-10 Y Y U-219
N021485 1 CARBIDOPA; ENTACAPONE; LEVODOPA 5446194 19-Oct-13 Y


N050685 2 CEFTIBUTEN DIHYDRATE 5599557 30-Apr-13
Y

N020998 1 CELECOXIB 5466823 30-Nov-13 Y


N020998 1 CELECOXIB 5563165 30-Nov-13
Y

N020989 2 CEVIMELINE HYDROCHLORIDE 5340821 7-Jul-13

U-309
N019537 1 CIPROFLOXACIN HYDROCHLORIDE 5286754 15-Feb-11



N019537 1 CIPROFLOXACIN HYDROCHLORIDE 5286754*PED 15-Aug-11



N022331 1 CLONIDINE HYDROCHLORIDE 5869100 13-Oct-13
Y

N020839 1 CLOPIDOGREL BISULFATE 4847265 17-Nov-11 Y Y

N020839 1 CLOPIDOGREL BISULFATE 4847265*PED 17-May-12



N020222 1 COLESTIPOL HYDROCHLORIDE 5490987 13-Feb-13
Y

N050715 1 CYCLOSPORINE 5342625 30-Aug-11
Y

N050715 1 CYCLOSPORINE 6258808 25-Jun-12
Y

N050715 1 CYCLOSPORINE 6262022 25-Jun-12
Y

N050715 1 CYCLOSPORINE 5741512 30-Aug-11
Y U-906
D
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N022250 1 DALFAMPRIDINE 5370879 6-Dec-11
Y

N022250 1 DALFAMPRIDINE 5540938 30-Jul-13

U-1030
N021976 1 DARUNAVIR ETHANOLATE 6335460 25-Aug-12 Y Y U-903
N020705 1 DELAVIRDINE MESYLATE 5563142 8-Oct-13



N021312 1 DESLORATADINE 5178878*PED 12-Jul-10



N021879 1 DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE 5206248 27-Mar-12

U-1093
N021879 1 DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE 5166207 17-Jun-11

U-1093
N020931 1 DOFETILIDE 4959366 25-Sep-12 Y Y U-652
N020062 1 DILTIAZEM HYDROCHLORIDE 5364620 14-Nov-11

U-3
N020062 2 DILTIAZEM HYDROCHLORIDE 5286497 20-May-11



N021392 1 DILTIAZEM HYDROCHLORIDE 5288505 26-Jun-11



N020062 1 DILTIAZEM HYDROCHLORIDE 5439689 8-Aug-12

U-107
N020062 1 DILTIAZEM HYDROCHLORIDE 5470584 20-May-11



N020401 1 DILTIAZEM HYDROCHLORIDE 5529791 25-Jun-13



N020092 1 DILTIAZEM HYDROCHLORIDE 5422123 6-Jun-12



N020623 1 DOLASETRON MESYLATE 4906755 2-Jul-11



N022568 1 DONEPEZIL HYDROCHLORIDE 4895841 25-Nov-10 Y Y U-322
N021427 1 DULOXETINE HYDROCHLORIDE 5023269 11-Jun-13 Y Y U-1094
N021319 1 DUTASTERIDE 5998427 17-Sep-13 Y Y U-477
N021319 1 DUTASTERIDE 5846976 17-Sep-13

U-476
E
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N021500 1 EMTRICITABINE 7402588*PED 1-Aug-10



N021500 1 EMTRICITABINE 5210085*PED 11-Nov-10



N021752 1 EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 5210085*PED 11-Nov-10



N020796 1 ENTACAPONE 5135950 31-Oct-10 Y Y U-219
N020796 1 ENTACAPONE 5446194 19-Oct-13 Y


N021476 1 ESZOPICLONE 6864257 30-Aug-12

U-629
N021476 2 ESZOPICLONE 7381724 16-Jan-12 Y Y U-629
N021476 3 ESZOPICLONE 6319926 16-Jan-12

U-620
N021476 1 ESZOPICLONE 7381724 16-Jan-12 Y Y U-629
N021560 1 EVEROLIMUS 6440990 24-Sep-13
Y U-1049
N020753 1 EXEMESTANE 4808616 1-Apr-11 Y Y U-658
N021445 1 EZETIMIBE 5846966 21-Sep-13

U-473
F
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020363 1 FAMCICLOVIR 5246937 21-Sep-10

U-96
N020363 1 FAMCICLOVIR 5246937*PED 21-Mar-11



N021656 1 FENOFIBRATE 5145684 25-Jan-11
Y U-615
N020788 1 FINASTERIDE 5547957 15-Oct-13

U-236
N020788 1 FINASTERIDE 5886184 19-Nov-12 Y


N020788 1 FINASTERIDE 6046183 20-Mar-11
Y U-577
N020788 1 FINASTERIDE 5571817 5-Nov-13

U-259
N021520 1 FLUOXETINE HYDROCHLORIDE; OLANZAPINE 5229382 23-Apr-11 Y Y

N021520 1 FLUOXETINE HYDROCHLORIDE; OLANZAPINE 5229382*PED 23-Oct-11



N021192 1 FLUVASTATIN SODIUM 5354772 11-Oct-11

U-109
N020261 2 FLUVASTATIN SODIUM 5354772*PED 11-Apr-12



N021192 1 FLUVASTATIN SODIUM 5356896 12-Dec-11



N021192 1 FLUVASTATIN SODIUM 5356896*PED 12-Jun-12



N021006 1 FROVATRIPTAN SUCCINATE 5962501 16-Dec-13

U-436
G
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N021399 1 GEFITINIB 5457105 19-Jan-13



N021399 1 GEFITINIB 5616582 19-Jan-13



N021925 1 GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE 4687777 17-Jan-11 Y


N021700 1 GLIMEPIRIDE; ROSIGLITAZONE MALEATE 5002953 17-Sep-11 Y Y U-690
N021700 5 GLIMEPIRIDE; ROSIGLITAZONE MALEATE 5002953*PED 17-Mar-12



H
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020758 2 HYDROCHLOROTHIAZIDE; IRBESARTAN 5270317 30-Sep-11



N020758 2 HYDROCHLOROTHIAZIDE; IRBESARTAN 5270317*PED 30-Mar-12



N020818 1 HYDROCHLOROTHIAZIDE; VALSARTAN 5399578 21-Mar-12

U-3
N020818 1 HYDROCHLOROTHIAZIDE; VALSARTAN 5399578*PED 21-Sep-12



I
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N021455 2 IBANDRONATE SODIUM 4927814 17-Mar-12 Y Y U-642
N022192 1 ILOPERIDONE RE39198 15-Nov-11 Y Y U-971
N020685 1 INDINAVIR SULFATE 5413999 9-May-12

U-132
N020757 1 IRBESARTAN 5270317 30-Sep-11



N020757 1 IRBESARTAN 5270317*PED 30-Mar-12



J
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
K
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
L
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020764 1 LAMOTRIGINE 5698226 29-Jan-12



N020764 4 LAMOTRIGINE 5698226*PED 29-Jul-12



N021003 1 LAMIVUDINE RE39155 2-Jul-13

U-250
N020857 1 LAMIVUDINE; ZIDOVUDINE 5859021 15-May-12 Y Y U-248
N020406 1 LANSOPRAZOLE 5464632 7-Nov-12



N021428 1 LANSOPRAZOLE 5464632*PED 7-May-13



N021428 1 LANSOPRAZOLE 5013743*PED 12-Aug-10



N020726 1 LETROZOLE 4978672 3-Jun-11

U-203
N022064 1 LEVOCETIRIZINE DIHYDROCHLORIDE 5698558 24-Sep-12

U-812
N022064 1 LEVOCETIRIZINE DIHYDROCHLORIDE 5698558*PED 24-Mar-13



N020634 1 LEVOFLOXACIN 5053407 20-Dec-10



N020634 1 LEVOFLOXACIN 5053407*PED 20-Jun-11



N021226 2 LOPINAVIR; RITONAVIR 5886036 19-Nov-13 Y Y U-895
N021906 1 LOPINAVIR; RITONAVIR 5541206 30-Jul-13

U-348
N020386 1 LOSARTAN POTASSIUM 5210079*PED 11-Nov-10

U-496
N021249 1 LOVASTATIN; NIACIN 6129930 20-Sep-13

U-448
N021249 1 LOVASTATIN; NIACIN 6406715 20-Sep-13
Y U-450
N021249 1 LOVASTATIN; NIACIN 6746691 20-Sep-13

U-586
N021249 1 LOVASTATIN; NIACIN 6818229 20-Sep-13
Y

N021249 1 LOVASTATIN; NIACIN 7011848 20-Sep-13

U-712
N021908 1 LUBIPROSTONE 5317032 31-May-11

U-874
M
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N019651 1 MESALAMINE 5541170 30-Jul-13

U-141
N019651 1 MESALAMINE 5541171 30-Jul-13

U-141
N020855 1 MESNA 5252341 16-Jul-11



N020855 1 MESNA 5262169 16-Jul-11



N021842 1 METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE 4687777 17-Jan-11 Y


N021410 2 METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE 5002953 17-Sep-11 Y Y U-493
N021410 2 METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE 5002953*PED 17-Mar-12



N021348 1 MIGLUSTAT 5472969 13-May-13



N021348 1 MIGLUSTAT 5525616 11-Jun-13



N021409 1 MONTELUKAST SODIUM 5565473 3-Feb-12 Y Y U-807
N021409 1 MONTELUKAST SODIUM 5565473*PED 3-Aug-12



N
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020763 1 NARATRIPTAN HYDROCHLORIDE 4997841 7-Jul-10

U-232
N021204 1 NATEGLINIDE 5463116 21-Oct-12



N021204 1 NATEGLINIDE 5488150 30-Jan-13



N021503 1 NELFINAVIR MESYLATE 5484926 7-Oct-13



N021503 1 NELFINAVIR MESYLATE 5952343 7-Oct-13

U-257
N020778 1 NELFINAVIR MESYLATE 6162812 7-Oct-13

U-248
N020381 2 NIACIN 6129930 20-Sep-13

U-354
N020381 2 NIACIN 6406715 20-Sep-13

U-450
N020381 2 NIACIN 6746691 20-Sep-13

U-586
N020381 2 NIACIN 6818229 20-Sep-13
Y

N020381 2 NIACIN 7011848 20-Sep-13

U-712
N022078 1 NIACIN; SIMVASTATIN 6129930 20-Sep-13
Y U-862
N022078 1 NIACIN; SIMVASTATIN 6406715 20-Sep-13
Y

N022078 1 NIACIN; SIMVASTATIN 6746691 20-Sep-13
Y

N022078 1 NIACIN; SIMVASTATIN 6818229 20-Sep-13
Y

N022078 1 NIACIN; SIMVASTATIN 7011848 20-Sep-13

U-862
N019684 1 NIFEDIPINE 5264446 23-Nov-10



N020356 5 NISOLDIPINE 5422123 6-Jun-12
Y

N021497 1 NITAZOXANIDE 5578621 26-Nov-13
Y U-525
N021232 1 NITISINONE 5550165 27-Aug-13



O
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020592 1 OLANZAPINE 5229382 23-Apr-11

U-324
N021086 1 OLANZAPINE 5229382*PED 23-Oct-11



N021086 1 OLANZAPINE 5627178 23-Apr-11

U-364
N020592 1 OLANZAPINE 5627178*PED 23-Oct-11



N020592 1 OLANZAPINE 5817655 23-Apr-11

U-364
N020592 1 OLANZAPINE 5817655*PED 23-Oct-11



N020592 1 OLANZAPINE 5817656 23-Apr-11

U-360
N020592 1 OLANZAPINE 5817656*PED 23-Oct-11



N020592 1 OLANZAPINE 5817657 23-Apr-11

U-363
N020592 1 OLANZAPINE 5817657*PED 23-Oct-11



N021654 1 OMEGA-3-ACID ETHYL ESTERS 5502077 26-Mar-13 Y
U-822
N020103 1 ONDANSETRON HYDROCHLORIDE 5344658 6-Sep-11



N020103 1 ONDANSETRON HYDROCHLORIDE 5344658*PED 6-Mar-12



N013718 1 OXANDROLONE 6670351 20-Oct-12

U-585
N022272 1 OXYCODONE HYDROCHLORIDE 5508042 16-Apr-13

U-443
N021610 1 OXYMORPHONE HYDROCHLORIDE 5662933 9-Sep-13
Y

N021610 7 OXYMORPHONE HYDROCHLORIDE 5958456 9-Sep-13
Y

P
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N021999 1 PALIPERIDONE 5158952 9-Apr-12
Y U-90
N021999 1 PALIPERIDONE 5158952*PED 9-Oct-12



N020936 2 PAROXETINE HYDROCHLORIDE 5422123 6-Jun-12



N020936 2 PAROXETINE HYDROCHLORIDE 5422123*PED 6-Dec-12



N021073 1 PIOGLITAZONE HYDROCHLORIDE 4687777 17-Jan-11



N022421 1 PRAMIPEXOLE DIHYDROCHLORIDE 4886812 8-Oct-10 Y Y

N022307 1 PRASUGREL HYDROCHLORIDE 5288726 8-Sep-12 Y Y U-991
Q
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020639 1 QUETIAPINE FUMARATE 4879288 26-Sep-11 Y Y U-550
N020639 1 QUETIAPINE FUMARATE 4879288*PED 26-Mar-12



R
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020973 2 RABEPRAZOLE SODIUM 5045552 8-May-13

U-385
N020815 1 RALOXIFENE HYDROCHLORIDE 5393763 28-Jul-12

U-114
N020815 1 RALOXIFENE HYDROCHLORIDE RE38968 28-Jul-12

U-657
N020815 1 RALOXIFENE HYDROCHLORIDE RE39049 28-Jul-12

U-657
N020815 1 RALOXIFENE HYDROCHLORIDE 5457117 28-Jul-12

U-114 Y
N019901 1 RAMIPRIL 5403856 4-Apr-12

U-71
N021641 1 RASAGILINE MESYLATE 5387612 7-Feb-12

U-219
N021641 1 RASAGILINE MESYLATE 5786390 7-Feb-12
Y

N021641 1 RASAGILINE MESYLATE 5457133 7-Feb-12 Y Y

N021641 1 RASAGILINE MESYLATE 5532415 2-Jul-13 Y


N020599 1 RILUZOLE 5527814 18-Jun-13



N020835 1 RISEDRONATE SODIUM 6096342 22-Nov-11



N020835 1 RISEDRONATE SODIUM 6096342*PED 22-May-12



N020835 1 RISEDRONATE SODIUM 5583122 10-Dec-13

U-222
N020945 1 RITONAVIR 5541206 30-Jul-13

U-348
N020865 1 RIZATRIPTAN BENZOATE 5457895 1-Oct-13



N022008 1 ROPINIROLE HYDROCHLORIDE 5422123 6-Jun-12
Y

N021071 2 ROSIGLITAZONE MALEATE 5002953 17-Sep-11 Y Y U-329
N021071 2 ROSIGLITAZONE MALEATE 5002953*PED 17-Mar-12



S
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020628 1 SAQUINAVIR MESYLATE 5196438 19-Nov-10



N020628 1 SAQUINAVIR MESYLATE 5196438*PED 19-May-11



N019839 1 SERTRALINE HYDROCHLORIDE 5248699 13-Aug-12



N019839 1 SERTRALINE HYDROCHLORIDE 5248699*PED 13-Feb-13



N022127 1 SEVELAMER CARBONATE 6858203 11-Aug-13
Y U-246
N022127 1 SEVELAMER CARBONATE 5496545 11-Aug-13
Y U-246
N022127 1 SEVELAMER CARBONATE 6509013 11-Aug-13
Y

N022127 1 SEVELAMER CARBONATE 7014846 11-Aug-13
Y U-246
N022127 1 SEVELAMER CARBONATE 7459151 11-Aug-13

U-246
N020895 1 SILDENAFIL CITRATE 5250534 27-Mar-12



N022206 1 SILODOSIN 5403847 13-Nov-12

U-902
N022206 1 SILODOSIN 6015819 13-Nov-12

U-902
N021110 1 SIROLIMUS 5100899 7-Jul-13

U-290
N021110 1 SIROLIMUS 5145684 25-Jan-11
Y U-857
N021110 2 SIROLIMUS 5212155*PED 18-Nov-10



N021097 1 SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 5616346 18-May-13

U-359
T
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N021029 1 TEMOZOLOMIDE 5260291 11-Aug-13 Y Y U-619
N020347 1 TERAZOSIN HYDROCHLORIDE 5294615 29-Apr-13

U-165
N020347 1 TERAZOSIN HYDROCHLORIDE 5412095 29-Apr-13



N020785 3 THALIDOMIDE 6235756 1-Mar-13

U-731
N020646 1 TIAGABINE HYDROCHLORIDE 5354760 24-Mar-12



N020646 1 TIAGABINE HYDROCHLORIDE 5010090 30-Sep-11



N020697 2 TOLCAPONE 5236952 29-Jan-12



N020771 1 TOLTERODINE TARTRATE 5382600 25-Mar-12



N020771 1 TOLTERODINE TARTRATE 5382600*PED 25-Sep-12



N020771 1 TOLTERODINE TARTRATE 5559269 5-Nov-13

U-318 Y
N022275 1 TOLVAPTAN 5258510 2-Nov-10 Y


N021693 1 TRAMADOL HYDROCHLORIDE 5464632 22-Mar-13
Y

U
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
V
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N021283 1 VALSARTAN 5399578 21-Mar-12



N021283 1 VALSARTAN 5399578*PED 21-Sep-12



N020699 4 VENLAFAXINE HYDROCHLORIDE 6444708 28-Jun-13

U-398
N020699 4 VENLAFAXINE HYDROCHLORIDE 6444708*PED 28-Dec-13

U-398
N020699 1 VENLAFAXINE HYDROCHLORIDE 5916923 28-Jun-13

U-398
N020699 1 VENLAFAXINE HYDROCHLORIDE 5916923*PED 28-Dec-13

U-398
N020699 1 VENLAFAXINE HYDROCHLORIDE 6310101 28-Jun-13

U-46
N020552 2 VERAPAMIL HYDROCHLORIDE 5252338 27-Jun-11



N021266 1 VORICONAZOLE 5364938 15-Nov-11 Y


N021266 1 VORICONAZOLE 5773443 25-Jan-11 Y Y U-540
N021991 1 VORINOSTAT 6087367 4-Oct-11

U-776
N021991 1 VORINOSTAT RE38506 29-Nov-11 Y Y

W
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
X
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
Y
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
Z
Appl No Prod No Active Ingredient Patent No Patent Expire Drug Substance Drug Product Patent Use Delist
Claim Claim Code Requested
N020547 1 ZAFIRLUKAST 4859692 26-Sep-10



N020547 1 ZAFIRLUKAST 5294636 11-Dec-11



N020547 1 ZAFIRLUKAST 5482963 9-Jan-13



N020547 1 ZAFIRLUKAST 5319097 11-Dec-11



N020547 1 ZAFIRLUKAST 5583152 26-Sep-10



N020547 1 ZAFIRLUKAST 6143775 11-Dec-11



N022052 3 ZILEUTON 4873259 10-Dec-10

U-168
N020471 1 ZILEUTON 5422123 6-Jun-12
Y

N020825 1 ZIPRASIDONE HYDROCHLORIDE 4831031 2-Mar-12 Y Y U-720
N020825 1 ZIPRASIDONE HYDROCHLORIDE 5312925 1-Sep-12 Y Y

N020768 2 ZOLMITRIPTAN 5466699 14-Nov-12



N020768 2 ZOLMITRIPTAN 5466699*PED 14-May-13



N020768 1 ZOLMITRIPTAN 5863935 14-Nov-12



N020768 1 ZOLMITRIPTAN 5863935*PED 14-May-13



© Copyright , Innvelop Pharmaceuticals Pvt. Ltd. All Rights Reserved.